We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Stada Arzneimittel confirmed Sunday that it received two non-binding takeover proposals, including a 3.6-billion euros ($3.8 billion) bid from private equity group Cinven at 56 euros ($59.50) per share, representing a 15-percent premium to Stada's closing